CompoAtlas

OBP

Natural health product licensed in Canada

Other names
Advanced Bone Protection (ABP), OSTEONOx, OSTEONOx3,2,1
Licence holder
Advanced Orthomolecular Research Inc.
NPN or DIN-HM
80014819
Status
Active licence
Licence date
19 November 2009
Revision date
6 June 2019
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Milk basic protein

Source : Lait de vache

40 mgNot calculated

Non-medicinal ingredients

Eau, Sodium Stearyl Fumarate, Microcrystalline cellulose, Sorbitol, Hypromellose, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
FemmesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

OBP¿ (Osteo-Bone Protection) contains MBP, an active protein complex from the whey fraction of milk. Research demonstrates that MBP can positively impact bone health by reducing bone loss (resorption) and increasing bone mineral density.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80014819

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line